Ipca Lab spurts after Q1 PAT soars 244%

Image
Capital Market
Last Updated : Aug 10 2020 | 2:51 PM IST

Ipca Laboratories rallied 8.30% to Rs 2,118 after consolidated net profit surged 244% to Rs 445.68 crore on 42.31% jump in net sales to Rs 1,534.40 crore in Q1 June 2020 over Q1 June 2019.

Profit before tax (PBT) soared 227.11% to Rs 545.57 crore in Q1 June 2020 as against Rs 166.78 crore in Q1 June 2019. Tax expense for the quarter jumped 167% to Rs 99.89 crore as against Rs 37.35 crore paid in Q1 June 2019.

Revenue from formulations business jumped 37% to Rs 953.05 crore and revenue from Active Pharmaceutical Ingredients (APIs) business spurted 72% to Rs 513.29 crore during the quarter.

Consolidated EBITDA (before forex) spurted 183% to Rs 594.42 crore in Q1 June 2020 over Q1 June 2019. The Q1 result was declared during market hours today, 10 August 2020.

IPCA Laboratories is a vertically integrated pharmaceutical company. It produces finished dosage forms and active pharmaceutical ingredients.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 10 2020 | 2:23 PM IST

Next Story